Maxcyte (MXCT) Gains from Investment Securities (2019 - 2026)
Maxcyte (MXCT) reported Gains from Investment Securities of $625000.0 for Q1 2026, up 1429.79% year-over-year from $40855.4 in Q1 2025, and up 1853.12% on a QoQ basis from $32000.0 in Q4 2025.
Maxcyte (MXCT) has 8 years of Gains from Investment Securities data on file, last reported at $625000.0 in Q1 2026.
- Quarterly Gains from Investment Securities rose 1429.79% year-over-year to $625000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $625000.0 (down 90.4% YoY) and the FY2025 annual result came in at $8.4 million, up 337.55% from the prior year.
- Gains from Investment Securities rose to $625000.0 in Q1 2026 per MXCT's latest filing, from $32000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $6.4 million in Q2 2023 and bottomed at -$410000.0 in Q1 2023.
- The 5-year median for Gains from Investment Securities is $740450.0 (2022), against an average of $1.9 million.
- Peak annual rise in Gains from Investment Securities reached 3135.84% in 2023, while the deepest fall reached 122.89% in 2023.
- Tracing MXCT's Gains from Investment Securities over 5 years: stood at $132763.0 in 2022, then soared by 3135.84% to $4.3 million in 2023, then plunged by 37.85% to $2.7 million in 2024, then sank by 98.8% to $32000.0 in 2025, then jumped by 1853.12% to $625000.0 in 2026.
- Per Business Quant, the three latest MXCT Gains from Investment Securities figures stand at $625000.0 (Q1 2026), $32000.0 (Q4 2025), and $5.4 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Maxcyte | 129.85 Mn | 129.85 Mn | 8.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 625,000.00 |
| Mar 31, 2026 | 625,000.00 |
| Dec 31, 2025 | 32,000.00 |
| Dec 31, 2025 | 32,000.00 |
| Jun 30, 2025 | 5.44 Mn |
| Jun 30, 2025 | 5.44 Mn |
| Mar 31, 2025 | -47,000.00 |
| Mar 31, 2025 | -47,000.00 |
| Dec 31, 2024 | 2.67 Mn |
| Dec 31, 2024 | 2.67 Mn |
| Sep 30, 2024 | 550,838.00 |
| Sep 30, 2024 | 550,838.00 |
| Jun 30, 2024 | 550,838.00 |
| Jun 30, 2024 | 550,838.00 |
| Mar 31, 2024 | 550,838.00 |
| Mar 31, 2024 | 550,838.00 |
| Dec 31, 2023 | 4.30 Mn |
| Dec 31, 2023 | 4.30 Mn |
| Sep 30, 2023 | 6.25 Mn |
| Sep 30, 2023 | 6.25 Mn |
| Jun 30, 2023 | 6.39 Mn |
| Jun 30, 2023 | 6.39 Mn |
| Mar 31, 2023 | -410,000.00 |
| Mar 31, 2023 | -410,000.00 |
| Dec 31, 2022 | 132,763.00 |
| Dec 31, 2022 | 132,763.00 |
| Sep 30, 2022 | 855,900.00 |
| Sep 30, 2022 | 855,900.00 |
| Jun 30, 2022 | 855,900.00 |
| Jun 30, 2022 | 855,900.00 |
| Mar 31, 2022 | 1.79 Mn |
| Mar 31, 2022 | 1.79 Mn |
| Dec 31, 2021 | 84,600.00 |
| Dec 31, 2021 | 84,600.00 |
| Sep 30, 2021 | 4.60 Mn |
| Sep 30, 2021 | 4.60 Mn |
| Jun 30, 2021 | 4.09 Mn |
| Jun 30, 2021 | 4.09 Mn |
| Mar 31, 2021 | 347,900.00 |
| Mar 31, 2021 | 347,900.00 |
| Dec 31, 2020 | -65,400.00 |
| Dec 31, 2020 | -65,400.00 |
| Sep 30, 2020 | 90,800.00 |
| Sep 30, 2020 | 90,800.00 |
| Dec 31, 2019 | 2.54 Mn |
| Dec 31, 2019 | 2.54 Mn |